Acadia Pharmaceuticals buy BMO Capital Markets
Start price
19.05.25
/
50%
€19.41
Target price
19.05.26
€25.05
Performance (%)
-5.82%
Price
06.05.26
€18.28
Summary
This prediction is currently active. With a performance of -5.82%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 19.05.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -3.916% | -3.916% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at BMO Capital Markets from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.27
27.06.24
27.06.24
€28.91
27.06.25
27.06.25
23.25%
28.06.25
28.06.25
